Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses-Reference-Cited by-同舟云学术

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses

Published:2017-07-11 Issue:12 Volume:13 Page:2849-2858
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Stenler S.¹,Lundin K. E.²,Hansen L.³,Petkov S.³,Mozafari N.²,Isaguliants M.³,Blomberg P.¹,Smith C. I. E.²,Goldenberg D. M.⁴⁵,Chang C.-H.⁴⁵,Ljungberg K.³,Hinkula J.⁶,Wahren B.³

Affiliation:

1. Karolinska Cell Therapy Center, Karolinska University Hospital, Stockholm, Sweden

2. Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Huddinge, Sweden

3. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

4. Immunomedics, Inc., Morris Plains, NJ, USA

5. IBC Pharmaceuticals, Inc., Morris Plains, NJ, USA

6. Department of Molecular Virology, Linköping University, Linköping, Sweden

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1338546

Reference51 articles.

1. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes

2. The fusion inhibitor enfuvirtide in recent antiretroviral strategies

3. Identification and characterization of a subpocket on the N-trimer of HIV-1 Gp41

4. A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro

5. The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice;Vaccines;2022-12-21

2. Biotechnology applications in infectious disease;Biotechnology in Healthcare;2022

3. Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity;Scientific Reports;2018-05-24

4. Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice;Viruses;2017-08-08